Event Archive

2018 Events

Neuroscience 2018
Hosted by The Society for Neuroscience
November 3, 2018 - November 7, 2018
San Diego, CA

The Third International Symposium on Sigma-2 Receptors: Role in Health and Disease
November 3, 2018
Roy’s Restaurant, San Diego, California

Alzheimer’s Association International Conference
July 22, 2018 - July 28, 2018
McCormick Place, Chicago, Illinois

Advances in Alzheimer Therapy (AAT) and AD/PD
March 15, 2018 - March 18, 2018
The Centro Congressi Lingotto, Torino, Italy

American Society for Experimental Neurotherapeutics (ASENT)
March 7, 2018 - March 10, 2018
Hilton Washington DC, Rockville, MD

The 2nd Annual Neuroscience Innovation Forum
Hosted by Sachs Associates
January 7, 2018
Marine’s Memorial Club, San Francisco, CA

2017 Events

Stifel 2017 Healthcare Conference
November 15, 2017
Lotte New York Palace Hotel, New York, NY

10th Clinical Trials on Alzheimer’s Disease (CTAD)
Presentation: The Anti-AB Oligomer Drug CT1812 for Alzheimer’s: Phase 1b/2a Safety Trial Outcomes
Poster: Biomarker Outcomes from the Phase 1b/2a Safety Trial of the Anti-AB Oligomer Drug CT1812 in Alzheimer’s Patients
November 1, 2017 - November 7, 2017
Boston Park Plaza Hotel, Boston, MA

Ladenburg Thalmann Healthcare Conference
September 26, 2017
Sofitel New York Hotel, New York, NY

Mizuho CNS Deep Management Day
September 9, 2017
The Langham Boston, Boston, MA

254th American Chemical Society National Meeting & Exposition
August 20, 2017 - August 24, 2017
Walter E. Washington Convention Center, Washington, DC

Canaccord Genuity Growth Conference
August 10, 2017
InterContinental Hotel Boston, MA

Alzheimer’s Association International Conference (AAIC)
Poster: A Phase 1 Safety Trial of the AB Oligomer Receptor Antagonist CT1812
July 16, 2017 - July 20, 2017
London, UK

Future Leaders in the Biotech Industry
Hosted by BioCentury Publications
April 7, 2017
Millennium Broadway Hotel & Conference Center, New York, NY

Alzheimer’s & Parkinson’s Diseases Congress – AD/PD™
Presentation: Translational Research in Drug Discovery for AD: a Plethora of Targets: Which is the Best, is There “a Best One”
March 29, 2017 - April 2, 2017
Vienna, Austria

2016 Events

9th Clinical Trials in Alzheimer’s Disease (CTAD)
Poster: CT1812, a drug candidate for Alzheimer’s disease, achieves predicted therapeutic concentrations after multiple dosing in healthy human volunteers
December 8, 2016 - December 10, 2016
San Diego, CA

Neuroscience 2016
Hosted by Society for Neuroscience
Poster: Characterization of alpha synuclein oligomers from Parkinson’s patient tissue
Poster: Identification of drug candidates that block the effects of alpha-synuclein oligomers on membrane trafficking
Poster: Sigma-2/PGRMC1 antagonist pharmacodynamic target engagement biomarker discovery for Alzheimer’s disease
Poster: Sigma-2/PGRMC1 antagonists as disease-modifying therapeutics for Alzheimer’s disease
Poster: On the identity of sigma-2 binding sites and PGRMC1: evidence in neurons relating to Alzheimer’s disease
November 12, 2016 - November 16, 2016
San Diego, CA

Alzheimer’s Association International Conference (AAIC)
Poster: A Two-Part, Double-Blind, Placebo-Controlled, Phase 1 Study of the Safety and Pharmacokinetics of Single and Multiple Ascending Doses of CT1812 in Healthy Volunteers
July 24, 2016 - July 28, 2016
Toronto, Ontario, Canada

Earlier Events

Alzheimer’s & Parkinson’s Diseases Congress – AD/PD™
Presentation: ABeta 42 Oligomer Binding to Neuronal Sigma-2/Pgrmc1 Receptors is Displaced by Drug Candidates that Improve Cognitive Deficits
March 18, 2015 - March 22, 2015
Nice, France

American Academy of Neurology
Poster: An ABeta Antagonist and Antibodies to Specific Target Receptor Epitopes Displace ABeta in Alzheimer’s Patient Brain Tissue Sections
April 26, 2014 - May 6, 2014
Philadelphia, PA

Labroots BioConference Live: Neuroscience
Presentation: ABeta Oligomer Receptor Antagonists as Disease Modifying Alzheimer’s Therapeutics
March 19, 2014 - March 20, 2014
Virtual Meeting (YouTube)